vs

Side-by-side financial comparison of CTO Realty Growth, Inc. (CTO) and OptimizeRx Corp (OPRX). Click either name above to swap in a different company.

CTO Realty Growth, Inc. is the larger business by last-quarter revenue ($41.2M vs $32.2M, roughly 1.3× OptimizeRx Corp). OptimizeRx Corp runs the higher net margin — 15.6% vs 15.1%, a 0.5% gap on every dollar of revenue. On growth, CTO Realty Growth, Inc. posted the faster year-over-year revenue change (15.0% vs -0.2%). Over the past eight quarters, OptimizeRx Corp's revenue compounded faster (28.0% CAGR vs 19.5%).

Keller Williams Realty is an American technology and international real estate franchise with headquarters in Austin, Texas. It is the largest real estate franchise in the United States by sales volume as of 2022.

OptimizeRx Corp is a U.S.-headquartered digital health technology company that delivers patient engagement, medication affordability and clinical communication solutions to life sciences enterprises, healthcare providers and pharmacy partners. Its core offerings include digital medication savings tools, patient support programs, and therapeutic area-specific resources to boost medication access and treatment adherence.

CTO vs OPRX — Head-to-Head

Bigger by revenue
CTO
CTO
1.3× larger
CTO
$41.2M
$32.2M
OPRX
Growing faster (revenue YoY)
CTO
CTO
+15.2% gap
CTO
15.0%
-0.2%
OPRX
Higher net margin
OPRX
OPRX
0.5% more per $
OPRX
15.6%
15.1%
CTO
Faster 2-yr revenue CAGR
OPRX
OPRX
Annualised
OPRX
28.0%
19.5%
CTO

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CTO
CTO
OPRX
OPRX
Revenue
$41.2M
$32.2M
Net Profit
$6.2M
$5.0M
Gross Margin
74.8%
Operating Margin
175.0%
26.6%
Net Margin
15.1%
15.6%
Revenue YoY
15.0%
-0.2%
Net Profit YoY
174.4%
6535.9%
EPS (diluted)
$0.13
$0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTO
CTO
OPRX
OPRX
Q1 26
$41.2M
Q4 25
$38.3M
$32.2M
Q3 25
$37.8M
$26.1M
Q2 25
$37.6M
$29.2M
Q1 25
$35.8M
$21.9M
Q4 24
$35.7M
$32.3M
Q3 24
$31.8M
$21.3M
Q2 24
$28.8M
$18.8M
Net Profit
CTO
CTO
OPRX
OPRX
Q1 26
$6.2M
Q4 25
$28.3M
$5.0M
Q3 25
$2.9M
$779.0K
Q2 25
$-23.4M
$1.5M
Q1 25
$2.3M
$-2.2M
Q4 24
$-15.2M
$-78.0K
Q3 24
$6.2M
$-9.1M
Q2 24
$1.2M
$-4.0M
Gross Margin
CTO
CTO
OPRX
OPRX
Q1 26
Q4 25
75.0%
74.8%
Q3 25
75.4%
67.2%
Q2 25
73.0%
63.8%
Q1 25
75.2%
60.9%
Q4 24
74.4%
68.1%
Q3 24
74.4%
63.1%
Q2 24
71.1%
62.2%
Operating Margin
CTO
CTO
OPRX
OPRX
Q1 26
175.0%
Q4 25
75.1%
26.6%
Q3 25
26.6%
7.9%
Q2 25
-33.7%
10.9%
Q1 25
22.0%
-9.6%
Q4 24
-20.4%
11.2%
Q3 24
15.6%
-40.2%
Q2 24
18.8%
-19.9%
Net Margin
CTO
CTO
OPRX
OPRX
Q1 26
15.1%
Q4 25
73.9%
15.6%
Q3 25
7.7%
3.0%
Q2 25
-62.2%
5.2%
Q1 25
6.3%
-10.0%
Q4 24
-42.6%
-0.2%
Q3 24
19.6%
-42.8%
Q2 24
4.1%
-21.3%
EPS (diluted)
CTO
CTO
OPRX
OPRX
Q1 26
$0.13
Q4 25
$0.81
$0.27
Q3 25
$0.03
$0.04
Q2 25
$-0.77
$0.08
Q1 25
$0.01
$-0.12
Q4 24
$-0.69
$0.00
Q3 24
$0.17
$-0.50
Q2 24
$-0.03
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTO
CTO
OPRX
OPRX
Cash + ST InvestmentsLiquidity on hand
$8.3M
$23.4M
Total DebtLower is stronger
$26.3M
Stockholders' EquityBook value
$575.4M
$128.3M
Total Assets
$1.3B
$176.9M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTO
CTO
OPRX
OPRX
Q1 26
$8.3M
Q4 25
$6.5M
$23.4M
Q3 25
$9.3M
$19.5M
Q2 25
$8.6M
$16.6M
Q1 25
$8.4M
$16.6M
Q4 24
$9.0M
$13.4M
Q3 24
$8.2M
$16.1M
Q2 24
$4.8M
Total Debt
CTO
CTO
OPRX
OPRX
Q1 26
Q4 25
$616.3M
$26.3M
Q3 25
$604.2M
$28.8M
Q2 25
$605.4M
$29.3M
Q1 25
$602.2M
$33.8M
Q4 24
$519.0M
$34.3M
Q3 24
$526.8M
$36.8M
Q2 24
$482.7M
$37.3M
Stockholders' Equity
CTO
CTO
OPRX
OPRX
Q1 26
$575.4M
Q4 25
$567.3M
$128.3M
Q3 25
$557.3M
$122.3M
Q2 25
$574.1M
$119.3M
Q1 25
$593.9M
$116.3M
Q4 24
$612.8M
$117.0M
Q3 24
$595.8M
$114.5M
Q2 24
$491.8M
$121.0M
Total Assets
CTO
CTO
OPRX
OPRX
Q1 26
$1.3B
Q4 25
$1.3B
$176.9M
Q3 25
$1.2B
$170.3M
Q2 25
$1.2B
$169.3M
Q1 25
$1.2B
$167.8M
Q4 24
$1.2B
$171.2M
Q3 24
$1.2B
$165.2M
Q2 24
$1.0B
$172.9M
Debt / Equity
CTO
CTO
OPRX
OPRX
Q1 26
Q4 25
1.09×
0.20×
Q3 25
1.08×
0.24×
Q2 25
1.05×
0.25×
Q1 25
1.01×
0.29×
Q4 24
0.85×
0.29×
Q3 24
0.88×
0.32×
Q2 24
0.98×
0.31×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTO
CTO
OPRX
OPRX
Operating Cash FlowLast quarter
$7.1M
Free Cash FlowOCF − Capex
$7.1M
FCF MarginFCF / Revenue
22.0%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
1.41×
TTM Free Cash FlowTrailing 4 quarters
$18.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTO
CTO
OPRX
OPRX
Q1 26
Q4 25
$64.6M
$7.1M
Q3 25
$25.5M
$3.2M
Q2 25
$21.9M
$4.6M
Q1 25
$10.3M
$3.9M
Q4 24
$59.9M
$198.0K
Q3 24
$21.2M
$1.8M
Q2 24
$12.9M
$782.0K
Free Cash Flow
CTO
CTO
OPRX
OPRX
Q1 26
Q4 25
$7.1M
Q3 25
$3.2M
Q2 25
$4.6M
Q1 25
$3.8M
Q4 24
$181.0K
Q3 24
$1.8M
Q2 24
$737.0K
FCF Margin
CTO
CTO
OPRX
OPRX
Q1 26
Q4 25
22.0%
Q3 25
12.2%
Q2 25
15.6%
Q1 25
17.5%
Q4 24
0.6%
Q3 24
8.3%
Q2 24
3.9%
Capex Intensity
CTO
CTO
OPRX
OPRX
Q1 26
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
0.1%
Q3 24
0.1%
Q2 24
0.2%
Cash Conversion
CTO
CTO
OPRX
OPRX
Q1 26
Q4 25
2.28×
1.41×
Q3 25
8.75×
4.11×
Q2 25
2.98×
Q1 25
4.56×
Q4 24
Q3 24
3.40×
Q2 24
10.89×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons